News

Lilly will offer higher doses of Zepbound on its website
Tourists in Israel and Lebanon have found themselves stranded at airports amid Israel's conflict with Iran. Fiona Jones ...
WUSF Public Media2h
A new chapter for online sales of obesity drug alternatives tests legal limits
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
The Lancet4d
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase ...
aNational Institute for Health and Care Research Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK bFaculty of Medicine ...
The Purdue Exponent5d
Real-World Results For GLP-1 Drugs Underwhelm, Study Says
WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...
Investing.com Nigeria5d
Hims & Hers stock falls after Lilly rules out partnership
Hims & Hers has been expanding its presence in the weight management market, with its existing Novo partnership representing ...
Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought
Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...
News-Medical.Net6d
Real-world study finds lower weight loss with GLP-1 drugs due to early discontinuation
A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...
Injectable medications for obesity found to produce smaller weight loss in a real-world setting
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...